Commonwealth Equity Services’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $845K | Buy |
46,408
+5,720
| +14% | +$104K | ﹤0.01% | 2722 |
|
|
2025
Q1 | $807K | Buy |
+40,688
| New | +$807K | ﹤0.01% | 2642 |
|
|
2024
Q4 | – | Sell |
-10,564
| Closed | -$211K | – | 4088 |
|
|
2024
Q3 | $211K | Sell |
10,564
-5,146
| -33% | -$103K | ﹤0.01% | 3648 |
|
|
2024
Q2 | $176K | Buy |
15,710
+2,950
| +23% | +$33K | ﹤0.01% | 3677 |
|
|
2024
Q1 | $84K | Sell |
12,760
-3,600
| -22% | -$23.7K | ﹤0.01% | 3828 |
|
|
2023
Q4 | $74K | Hold |
16,360
| – | – | ﹤0.01% | 3712 |
|
|
2023
Q3 | $59K | Buy |
16,360
+6,250
| +62% | +$22.5K | ﹤0.01% | 3640 |
|
|
2023
Q2 | $37K | Hold |
10,110
| – | – | ﹤0.01% | 3697 |
|
|
2023
Q1 | $33 | Sell |
10,110
-1,792
| -15% | -$6 | ﹤0.01% | 3620 |
|
|
2022
Q4 | $46K | Buy |
11,902
+1,792
| +18% | +$6.93K | ﹤0.01% | 3522 |
|
|
2022
Q3 | $24K | Buy |
+10,110
| New | +$24K | ﹤0.01% | 3556 |
|
|
2022
Q2 | – | Sell |
-26,010
| Closed | -$47K | – | 3664 |
|
|
2022
Q1 | $47K | Buy |
26,010
+3,000
| +13% | +$5.42K | ﹤0.01% | 3583 |
|
|
2021
Q4 | $32K | Sell |
23,010
-2,000
| -8% | -$2.78K | ﹤0.01% | 3573 |
|
|
2021
Q3 | $28K | Sell |
25,010
-5,000
| -17% | -$5.6K | ﹤0.01% | 3532 |
|
|
2021
Q2 | $48K | Sell |
30,010
-20,344
| -40% | -$32.5K | ﹤0.01% | 3463 |
|
|
2021
Q1 | $88K | Buy |
+50,354
| New | +$88K | ﹤0.01% | 3285 |
|